Home > Insider Trading > Filing (0001209191-13-045158)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368148	Athersys Inc / New	ATHX	Pharmaceutical Preparations (2834)	204864095

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402609	Jr William Lehmann	3201 Carnegie Avenue Cleveland OH 44115	President & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-09-18	15,704	$1.78	564,836	No	4	F	Direct
Common Stock	Disposition	2013-09-19	6,000	$1.84	558,836	No	4	S	Direct
Common Stock	Disposition	2013-09-20	6,000	$1.82	552,836	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares withheld from the quarterly vesting of a June 2013 restricted stock unit award to partially satisfy the related tax obligation.
Shares sold pursuant to a Rule 10b5-1 plan for tax and planning purposes related to the quarterly vesting of a June 2013 restricted stock unit award.
The price reported in Column 4 is a weighted average price. These shares were sold in mulitiple transactions at prices ranging from $ $1.79 to $1.89, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in mulitiple transactions at prices ranging from $ $1.80 to $1.87, inclusive.
Securities beneficially owned are comprised of: (1) 27,000 shares of common stock owned, and (2) 525,836 restricted stock units, awarded on June 20, 2013, related to the termination of 2005 incentive agreements and that will vest ratably, on a quarterly basis through June 18, 2016.